Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J E Kolitz

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Cancer Investigation|January 1, 1991
The immunotherapy of human cancer with interleukin 2: present status and future directionsJ E Kolitz, R Mertelsmann
Arzneimittel-Forschung|January 1, 1985
Interleukin 2: a reviewJ E Kolitz, K Welte, K W Sykora, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Leukemia|December 17, 2011
Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654AM S Spector, I Iossifov, A Kritharis, et al.
Cancer Genetics and Cytogenetics|October 1, 1981
A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemiaJ E Kolitz, P Schulman, N Kardon, et al.
Annals of Hematology|May 6, 2004
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adultsJ E Kolitz, S L George, M R Baer, et al.
Blood|March 1, 1988
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disordersH P Koeffler, D Heitjan, R Mertelsmann, et al.
Cancer Research|April 1, 1990
Pharmacokinetics of recombinant interleukin 2 in humansM W Konrad, G Hemstreet, E M Hersh, et al.
Oncology|January 1, 1988
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killingJ Atzpodien, S C Gulati, C Shimazaki, et al.
American Journal of Hematology|March 1, 1995
Morphological, ultrastructural, and genetic characterization of an unusual T-cell lymphoma in a patient with sinus histiocytosis with massive lymphadenopathyP R Koduru, M Susin, J E Kolitz, et al.
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Cancer Investigation|January 1, 1991
The immunotherapy of human cancer with interleukin 2: present status and future directionsJ E Kolitz, R Mertelsmann
Arzneimittel-Forschung|January 1, 1985
Interleukin 2: a reviewJ E Kolitz, K Welte, K W Sykora, et al.
Acta Haematologica|January 1, 1988
Cell-mediated toxicity of interleukin-2-activated lymphocytes against autologous and allogeneic human myeloma cellsC Shimazaki, J Atzpodien, D Wisniewski, et al.
Leukemia|December 17, 2011
Mast-cell leukemia exome sequencing reveals a mutation in the IgE mast-cell receptor β chain and KIT V654AM S Spector, I Iossifov, A Kritharis, et al.
Cancer Genetics and Cytogenetics|October 1, 1981
A complex variant Philadelphia (Ph1) chromosome translocation involving chromosomes No. 11, 14, and 22 in a case of chronic myelogenous leukemiaJ E Kolitz, P Schulman, N Kardon, et al.
Annals of Hematology|May 6, 2004
P-glycoprotein (Pgp) modulation in untreated acute myeloid leukemia (AML): Cancer and Leukemia Group B (CALGB) trials in younger and older adultsJ E Kolitz, S L George, M R Baer, et al.
Blood|March 1, 1988
Randomized study of 13-cis retinoic acid v placebo in the myelodysplastic disordersH P Koeffler, D Heitjan, R Mertelsmann, et al.
Cancer Research|April 1, 1990
Pharmacokinetics of recombinant interleukin 2 in humansM W Konrad, G Hemstreet, E M Hersh, et al.
Oncology|January 1, 1988
Ewing's sarcoma: ex vivo sensitivity towards natural and lymphokine-activated killingJ Atzpodien, S C Gulati, C Shimazaki, et al.
American Journal of Hematology|March 1, 1995
Morphological, ultrastructural, and genetic characterization of an unusual T-cell lymphoma in a patient with sinus histiocytosis with massive lymphadenopathyP R Koduru, M Susin, J E Kolitz, et al.
Pageof 4